Case Study: DCGI ordered the withdrawal of Voveran of Novartis
Posted on12 Jul 2018
TagsDCGI, diclofenac painkiller injection, Dynapar AQ, Product Recall, product withdrawal, themis, Transcutol-P, Voveran
Comments0
India’s drug regulator has ordered the withdrawal of the popular diclofenac painkiller injection marketed by Novartis India Ltd and made by Themis... Read More
Medical Science Liaison (MSL) – A Career Option for Healthcare Professionals !
What is The Medical Science Liaison (MSL)? The Medical Science Liaison (MSL) is a specific job related role within the healthcare industries, e.g.... Read More
NCK Pharma to introduce new edged “EMOTION BASED LEARNING” in the field of Pharmaceutical Learning
Bangalore (India), Press Release — NCK Pharma Solution Private Limited (popularly know as NCK), leading diversified training provider in the filed of... Read More
Basic Pharmacovigilance Competency Test
Abbreviated as PV or PhV, Pharmacovigilance is the science relating to the detection, assessment, understanding and prevention of adverse effects, particularly long term and short term side... Read More
FDA approves first-of-its-kind corneal implant
The U.S. Food and Drug Administration today approved the KAMRA inlay, a device implanted in the cornea of one eye (the clear,... Read More
10 New Molecular Entity approved by USFDA in 2015 till date
As on that 10 new molecular entity is approved by USFDA. No. Drug Active Ingredient FDA-approved use on approval date 10 Cholbam... Read More
FDA Launches Drug Shortages Mobile App
U.S. Food and Drug Administration launched the agency’s first mobile application (app) specifically designed to speed public access to valuable information about drug... Read More
US FDA issues warning on Pfizer’s Geodon
The US Food and Drug Administration is warning that the antipsychotic drug ziprasidone (marketed under the brand name Geodon by pharma giant... Read More
Ranbaxy launches India’s first biosimilar of infliximab drug ‘Infimab’
Ranbaxy Laboratories has launched Infimab (BOWO15), the first “Remicade” (infliximab) biosimilar in India through a licensing partnership with Epirus Biopharmaceuticals, Inc., a... Read More
What are the difference between regulatory affairs and pharmacovigilance working?
Pharmacovigilance professionals are focused on the science of collecting, monitoring, researching, assessing and evaluating information from healthcare providers and patients about the... Read More